149 related articles for article (PubMed ID: 23433112)
1. Somatic mutation patterns and compound response in cancers.
He N; Kim N; Yoon S
BMB Rep; 2013 Feb; 46(2):97-102. PubMed ID: 23433112
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of genotype-specific drug responses in cancer.
Kim N; He N; Kim C; Zhang F; Lu Y; Yu Q; Stemke-Hale K; Greshock J; Wooster R; Yoon S; Mills GB
Int J Cancer; 2012 Nov; 131(10):2456-64. PubMed ID: 22422301
[TBL] [Abstract][Full Text] [Related]
3. Combining Mutational Signatures, Clonal Fitness, and Drug Affinity to Define Drug-Specific Resistance Mutations in Cancer.
Kaserer T; Blagg J
Cell Chem Biol; 2018 Nov; 25(11):1359-1371.e2. PubMed ID: 30146241
[TBL] [Abstract][Full Text] [Related]
4. MACE: mutation-oriented profiling of chemical response and gene expression in cancers.
Jeong E; He N; Park H; Song M; Kim N; Lee S; Yoon S
Bioinformatics; 2015 May; 31(9):1508-14. PubMed ID: 25536965
[TBL] [Abstract][Full Text] [Related]
5. Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset.
Seashore-Ludlow B; Rees MG; Cheah JH; Cokol M; Price EV; Coletti ME; Jones V; Bodycombe NE; Soule CK; Gould J; Alexander B; Li A; Montgomery P; Wawer MJ; Kuru N; Kotz JD; Hon CS; Munoz B; Liefeld T; Dančík V; Bittker JA; Palmer M; Bradner JE; Shamji AF; Clemons PA; Schreiber SL
Cancer Discov; 2015 Nov; 5(11):1210-23. PubMed ID: 26482930
[TBL] [Abstract][Full Text] [Related]
6. A gene expression database for the molecular pharmacology of cancer.
Scherf U; Ross DT; Waltham M; Smith LH; Lee JK; Tanabe L; Kohn KW; Reinhold WC; Myers TG; Andrews DT; Scudiero DA; Eisen MB; Sausville EA; Pommier Y; Botstein D; Brown PO; Weinstein JN
Nat Genet; 2000 Mar; 24(3):236-44. PubMed ID: 10700175
[TBL] [Abstract][Full Text] [Related]
7. Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells.
Gautam P; Karhinen L; Szwajda A; Jha SK; Yadav B; Aittokallio T; Wennerberg K
Mol Cancer; 2016 May; 15(1):34. PubMed ID: 27165605
[TBL] [Abstract][Full Text] [Related]
8. Evaluating somatic tumor mutation detection without matched normal samples.
Teer JK; Zhang Y; Chen L; Welsh EA; Cress WD; Eschrich SA; Berglund AE
Hum Genomics; 2017 Sep; 11(1):22. PubMed ID: 28870239
[TBL] [Abstract][Full Text] [Related]
9. Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia.
Liao Z; Gu L; Vergalli J; Mariani SA; De Dominici M; Lokareddy RK; Dagvadorj A; Purushottamachar P; McCue PA; Trabulsi E; Lallas CD; Gupta S; Ellsworth E; Blackmon S; Ertel A; Fortina P; Leiby B; Xia G; Rui H; Hoang DT; Gomella LG; Cingolani G; Njar V; Pattabiraman N; Calabretta B; Nevalainen MT
Mol Cancer Ther; 2015 Aug; 14(8):1777-93. PubMed ID: 26026053
[TBL] [Abstract][Full Text] [Related]
10. mTCTScan: a comprehensive platform for annotation and prioritization of mutations affecting drug sensitivity in cancers.
Li MJ; Yao H; Huang D; Liu H; Liu Z; Xu H; Qin Y; Prinz J; Xia W; Wang P; Yan B; Tran NL; Kocher JP; Sham PC; Wang J
Nucleic Acids Res; 2017 Jul; 45(W1):W215-W221. PubMed ID: 28482068
[TBL] [Abstract][Full Text] [Related]
11. Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling.
McDermott U; Sharma SV; Dowell L; Greninger P; Montagut C; Lamb J; Archibald H; Raudales R; Tam A; Lee D; Rothenberg SM; Supko JG; Sordella R; Ulkus LE; Iafrate AJ; Maheswaran S; Njauw CN; Tsao H; Drew L; Hanke JH; Ma XJ; Erlander MG; Gray NS; Haber DA; Settleman J
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19936-41. PubMed ID: 18077425
[TBL] [Abstract][Full Text] [Related]
12. Cell-Line Selectivity Improves the Predictive Power of Pharmacogenomic Analyses and Helps Identify NADPH as Biomarker for Ferroptosis Sensitivity.
Shimada K; Hayano M; Pagano NC; Stockwell BR
Cell Chem Biol; 2016 Feb; 23(2):225-235. PubMed ID: 26853626
[TBL] [Abstract][Full Text] [Related]
13. Integrating LINCS Data to Evaluate Cancer Transcriptome Modifying Potential of Small-molecule Compounds for Drug Repositioning.
Zhao Y; Liu Y; Bai H
Comb Chem High Throughput Screen; 2021; 24(9):1340-1350. PubMed ID: 33109034
[TBL] [Abstract][Full Text] [Related]
14. Cancer in silico drug discovery: a systems biology tool for identifying candidate drugs to target specific molecular tumor subtypes.
San Lucas FA; Fowler J; Chang K; Kopetz S; Vilar E; Scheet P
Mol Cancer Ther; 2014 Dec; 13(12):3230-40. PubMed ID: 25349306
[TBL] [Abstract][Full Text] [Related]
15. Semi-Synthesis of Small Molecules of Aminocarbazoles: Tumor Growth Inhibition and Potential Impact on p53.
Long S; Loureiro JB; Carvalho C; Gales L; Saraiva L; Pinto MMM; Puthongking P; Sousa E
Molecules; 2021 Mar; 26(6):. PubMed ID: 33804175
[TBL] [Abstract][Full Text] [Related]
16. CancerResource--updated database of cancer-relevant proteins, mutations and interacting drugs.
Gohlke BO; Nickel J; Otto R; Dunkel M; Preissner R
Nucleic Acids Res; 2016 Jan; 44(D1):D932-7. PubMed ID: 26590406
[TBL] [Abstract][Full Text] [Related]
17. Data mining the NCI cancer cell line compound GI(50) values: identifying quinone subtypes effective against melanoma and leukemia cell classes.
Marx KA; O'Neil P; Hoffman P; Ujwal ML
J Chem Inf Comput Sci; 2003; 43(5):1652-67. PubMed ID: 14502500
[TBL] [Abstract][Full Text] [Related]
18. Correlation of PIK3Ca mutations with gene expression and drug sensitivity in NCI-60 cell lines.
Whyte DB; Holbeck SL
Biochem Biophys Res Commun; 2006 Feb; 340(2):469-75. PubMed ID: 16376301
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel p53 pathway activating small-molecule compounds reveals unexpected similarities with known therapeutic agents.
Peltonen K; Colis L; Liu H; Jäämaa S; Moore HM; Enbäck J; Laakkonen P; Vaahtokari A; Jones RJ; af Hällström TM; Laiho M
PLoS One; 2010 Sep; 5(9):e12996. PubMed ID: 20885994
[TBL] [Abstract][Full Text] [Related]
20. GDA, a web-based tool for Genomics and Drugs integrated analysis.
Caroli J; Sorrentino G; Forcato M; Del Sal G; Bicciato S
Nucleic Acids Res; 2018 Jul; 46(W1):W148-W156. PubMed ID: 29800349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
